GE HealthCare Technologies Inc. reports a 3% revenue increase to $4.8 billion in Q1 2025, surpassing expectations with a 50.8% jump in net income and a $1 billion share repurchase ...
GE HealthCare Technologies Inc. reports a 3% revenue increase to $4.8 billion in Q1 2025, with net income up 50.8%. The company also announces a $1 billion share repurchase program...
GE HealthCare reports a 3% revenue increase to $4.8 billion in Q1 2025, with net income jumping 50.8%. The company also announces a $1 billion share repurchase program and strategi...
GE HealthCare reports a 3% revenue increase to $4.8 billion in Q1 2025, surpassing expectations with a 50.8% jump in net income to $564 million. The company also announces a $1 bil...
GE HealthCare Technologies Inc. reports a 3% year-on-year revenue increase to $4.8 billion in Q1 2025, with net income jumping 50.8%. The company also announces a $1 billion share ...
GE HealthCare Technologies Inc. reported a 3% increase in Q1 revenue to $4.8 billion, surpassing expectations. Net income jumped by 50.8%, and EPS by 51.85%. The company also annou...
GE HealthCare Technologies Inc. reports a 3% revenue increase to $4.8 billion in Q1 2025, surpassing expectations with a 50.8% jump in net income and a strategic $1 billion share r...
GE HealthCare Technologies Inc. reports a 3% revenue increase to $4.8 billion in Q1 2025, surpassing expectations. Net income jumps 50.8% to $564 million, with EPS up 51.85% to $1....
GE HealthCare reports a 3% revenue increase to $4.8 billion in Q1 2025, with net income jumping 50.8% to $564 million. The company also announces a $1 billion share repurchase prog...
GE HealthCare's stock fell 14% after China announced export controls on rare earth materials, critical for medical technology, amid escalating US-China trade tensions.
GE HealthCare's shares fell 14% after China announced export controls on rare earth materials, crucial for medical imaging equipment, amid US-China trade tensions.
GE HealthCare's stock fell 14% after China imposed export controls on rare earth materials, crucial for medical equipment. The move, seen as retaliation against US tariffs, has spa...
GE HealthCare Technologies, Inc. sees a 14% stock drop after China announces rare earth export controls, sparking supply chain fears in healthcare technology.
GE HealthCare Technologies, Inc. shares plummeted 14% after China imposed export controls on rare earth materials, crucial for medical equipment. The move, part of retaliatory meas...
GE HealthCare's stock fell 14% after China announced export controls on rare earth materials, crucial for medical imaging. This move, seen as retaliation against US tariffs, has sp...
GE HealthCare Technologies' stock plummeted 14% after China announced export controls on rare earth materials, crucial for medical equipment, amid escalating US-China trade tension...
GE HealthCare's stock price fell by 14.02% to $61.9050 following China's ban on rare earth exports, signaling potential disruptions in global supply chains and the healthcare techn...
GE HealthCare Technologies Inc. reports a 2.1% revenue increase in Q4 2024, reaching $5.3 billion, with net income and EPS significantly rising. The company forecasts a promising a...
GE HealthCare reports a 2.1% revenue increase in Q4 2024, reaching $5.3 billion, with net income and EPS soaring by 78%. The company anticipates continued growth with a positive ou...
GE HealthCare Technologies Inc. reported a 2.1% increase in Q4 2024 revenue to $5.3 billion, with net income and EPS both up by 78%. The company also provided a positive outlook fo...
